Publications in collaboration with researchers from Universidad de León (11)

2023

  1. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

    Hepatology, Vol. 77, Núm. 5, pp. 1654-1669

2021

  1. Aging, gut microbiota and metabolic diseases: Management through physical exercise and nutritional interventions

    Nutrients, Vol. 13, Núm. 1, pp. 1-21

  2. Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission

    Nutrients, Vol. 13, Núm. 8

  3. The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation

    Antioxidants, Vol. 10, Núm. 12

2019

  1. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease

    Molecular Nutrition and Food Research, Vol. 63, Núm. 20

  2. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  3. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

2018

  1. Antioxidant, anti-inflammatory, and analgesic activities of Citrus reticulata Blanco leaves extracts: An in vivo and in vitro study

    Phytotherapie, Vol. 16, Núm. S1, pp. S130-S142

  2. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease

    Frontiers in Physiology, Vol. 9

2017

  1. Activités antioxydantes, anti-inflammatoires et analgésiques des extraits des feuilles de Citrus reticulata Blanco: étude in vivo et in vitro

    Phytotherapie, pp. 1-13

  2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation

    Free Radical Biology and Medicine, Vol. 102, pp. 188-202